Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes?

There is a lack of studies assessing if race impacts the efficacy of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) inhibitor (“statin”) therapy on renal transplantation (RTx) outcomes. We examined the association between statin therapy and RTx outcomes, while concurrently quantifying the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozieh, Mukoso N., Taber, David J., Egede, Leonard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008522/
https://www.ncbi.nlm.nih.gov/pubmed/26656377
http://dx.doi.org/10.1097/MD.0000000000002283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008522/
https://www.ncbi.nlm.nih.gov/pubmed/26656377
http://dx.doi.org/10.1097/MD.0000000000002283

Ejemplares similares